Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-EAWGALANWAVDSA-OH
3D-Ansicht

Biosynth logo

H-EAWGALANWAVDSA-OH

Ref. 3D-PP43616

1mg
294,00 €
10mg
351,00 €
100mg
594,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-EAWGALANWAVDSA-OH
Synonyme:
  • NH2-Glu-Ala-Trp-Gly-Ala-Leu-Ala-Asn-Trp-Ala-Val-Asp-Ser-Ala-OH
Beschreibung:

Peptide H-EAWGALANWAVDSA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EAWGALANWAVDSA-OH include the following: Opposing peripheral fates of tissue-restricted self antigen-specific conventional and regulatory CD4+ T cells Z Zhang, FP Legoux, SW Vaughan - European journal of , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201948180 Optimization of peptide vaccines to induce robust antitumor CD4 T-cell responses T Kumai, S Lee, HI Cho, H Sultan , H Kobayashi - Cancer immunology , 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/1/72/468740 Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection T Dileepan , JL Linehan , JJ Moon, M Pepper - PLoS , 2011 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002252 In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4+ T Cells in Tissues T Dileepan , HO Kim, PP Cleary, PJ Skinner - Plos one, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128862 Bim mediates apoptosis of CD127lo effector T cells and limits T cell memory S Wojciechowski, MB Jordan, Y Zhu - European journal of , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200635897 The neonatal CD4+ T cell response to a single epitope varies in genetically identical mice RW Nelson, MN Rajpal, MK Jenkins - The Journal of Immunology, 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/5/2115/105028 Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells M Pepper , JL Linehan , AJ Pagan , T Zell - Nature , 2010 - nature.comhttps://www.nature.com/articles/ni.1826 Delayed CTLA4-Ig treatment reverses ongoing alloantibody responses and rescues allografts from acute rejection JS Young, J Chen , ML Miller, V Vu, C Tian - American journal of , 2016 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956497/ Delayed cytotoxic T lymphocyte-associated protein 4-immunoglobulin treatment reverses ongoing alloantibody responses and rescues allografts from acute JS Young, J Chen , ML Miller, V Vu , C Tian - American Journal of , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S160061352200956X Equal expansion of endogenous transplant-specific regulatory T cell and recruitment into the allograft during rejection and tolerance JS Young, D Yin, AGL Vannier , ML Alegre - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01385 Optimal protection against Salmonella infection requires noncirculating memory JM Benoun , NG Peres , N Wang - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1808339115 Cutting edge: Bcl6-interacting corepressor contributes to germinal center T follicular helper cell formation and B cell helper function JA Yang, NJ Tubo , MD Gearhart - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/194/12/5604/98927 Control of Persistent Salmonella Infection Relies on Constant Thymic Output Despite Increased Peripheral Antigen-Specific T Cell Immunity JA Goggins, JR Kurtz, JB McLachlan - Pathogens, 2020 - mdpi.comhttps://www.mdpi.com/2076-0817/9/8/605 Polymicrobial sepsis chronic immunoparalysis is defined by diminished Ag-specific T cell-dependent B cell responses FV Sjaastad , SA Condotta, JA Kotov , KA Pape - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02532/full Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes C Lu , JD Klement , ML Ibrahim , W Xiao - for immunotherapy of , 2019 - Springerhttps://link.springer.com/article/10.1186/s40425-019-0635-8 Transgenic expression of a T cell epitope in Strongyloides ratti reveals that helminth-specific CD4+ T cells constitute both Th2 and Treg populations B Douglas, Y Wei , X Li, A Ferguson, LY Hung - PLoS , 2021 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009709 Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice AJ Pagan , NC Peters , A Debrabant - European journal of , 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201242715 CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs AJ Pagan , M Pepper , HH Chu , JM Green - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/189/6/2909/83518

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP43616 H-EAWGALANWAVDSA-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.